These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 8382000

  • 1. Role of primary chemotherapy in stage I and low-volume stage II nonseminomatous germ-cell testis tumors.
    Sternberg CN.
    Urol Clin North Am; 1993 Feb; 20(1):93-109. PubMed ID: 8382000
    [Abstract] [Full Text] [Related]

  • 2. Role of adjuvant chemotherapy in patients with stage II nonseminomatous germ-cell tumors.
    Motzer RJ, Bosl GJ.
    Urol Clin North Am; 1993 Feb; 20(1):111-6. PubMed ID: 8381992
    [Abstract] [Full Text] [Related]

  • 3. Evolution of the management of stage I nonseminomatous germ-cell tumors of the testis.
    Sogani PC.
    Urol Clin North Am; 1991 Aug; 18(3):561-73. PubMed ID: 1652171
    [Abstract] [Full Text] [Related]

  • 4. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM, Escaf Barmadah S, Guate Ortiz JL, Martín Huescar A, Fresno Forcelledo F, García Rodríguez J, Rodríguez Faba O, Jalón Monzón A, Rodríguez Martínez JJ.
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [Abstract] [Full Text] [Related]

  • 5. Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle.
    Yoon GH, Stein JP, Skinner DG.
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):75-85. PubMed ID: 15757440
    [Abstract] [Full Text] [Related]

  • 6. Adjuvant chemotherapy for stage II nonseminomatous germ cell tumors.
    Kondagunta GV, Motzer RJ.
    Urol Clin North Am; 2007 May; 34(2):179-85; abstract ix. PubMed ID: 17484923
    [Abstract] [Full Text] [Related]

  • 7. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
    Westermann DH, Schefer H, Thalmann GN, Karamitopoulou-Diamantis E, Fey MF, Studer UE.
    J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
    [Abstract] [Full Text] [Related]

  • 8. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
    Schmidt P, Haas RJ, Göbel U, Calaminus G.
    Klin Padiatr; 2002 Jan; 214(4):167-72. PubMed ID: 12165897
    [Abstract] [Full Text] [Related]

  • 9. Stage I nonseminomatous germ cell tumor of the testis: more questions than answers?
    Powles T.
    Hematol Oncol Clin North Am; 2011 Jun; 25(3):517-27,viii. PubMed ID: 21570606
    [Abstract] [Full Text] [Related]

  • 10. Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion.
    Stephenson AJ, Bosl GJ, Bajorin DF, Stasi J, Motzer RJ, Sheinfeld J.
    J Urol; 2005 Aug; 174(2):557-60; discussion 560. PubMed ID: 16006891
    [Abstract] [Full Text] [Related]

  • 11. Prognosis of patients after retroperitoneal lymphadenectomy for clinical stage I nonseminomatous germ cell tumour of the testis.
    Hornák M, Zvara V, Ondrus D, Bárdos A.
    Czech Med; 1987 Aug; 10(2):109-16. PubMed ID: 2820669
    [Abstract] [Full Text] [Related]

  • 12. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
    Böhlen D, Borner M, Sonntag RW, Fey MF, Studer UE.
    J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
    [Abstract] [Full Text] [Related]

  • 13. Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle: an update.
    Yoon GH, Stein JP, Skinner DG.
    Urol Oncol; 2005 Apr; 23(3):168-77. PubMed ID: 15907716
    [Abstract] [Full Text] [Related]

  • 14. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
    Ondrus D, Ondrusova M, Hornak M, Matoska J.
    Neoplasma; 2007 Apr; 54(5):437-42. PubMed ID: 17688374
    [Abstract] [Full Text] [Related]

  • 15. Surveillance versus nerve-sparing retroperitoneal lymphadenectomy in stage I nonseminomatous germ-cell tumors.
    Lowe BA.
    Urol Clin North Am; 1993 Feb; 20(1):75-83. PubMed ID: 8381999
    [Abstract] [Full Text] [Related]

  • 16. The management of stage I nonseminomatous testicular germ cell tumors.
    Pectasides D, Farmakis D, Pectasides M.
    Oncology; 2006 Feb; 71(3-4):151-8. PubMed ID: 17646698
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of patients with stage I-II non-seminoma germ-cell tumors of the testis].
    Sakalo VS, Klimenko IA, Zaparin VK, Gremko VN.
    Vopr Onkol; 1988 Feb; 34(5):608-12. PubMed ID: 2837872
    [Abstract] [Full Text] [Related]

  • 18. Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome.
    Stephenson AJ, Bosl GJ, Motzer RJ, Kattan MW, Stasi J, Bajorin DF, Sheinfeld J.
    J Clin Oncol; 2005 Apr 20; 23(12):2781-8. PubMed ID: 15837993
    [Abstract] [Full Text] [Related]

  • 19. Stage I testicular cancer.
    Scholz M, Höltl W.
    Curr Opin Urol; 2003 Nov 20; 13(6):473-6. PubMed ID: 14560141
    [Abstract] [Full Text] [Related]

  • 20. [Modified retroperitoneal lymphadenectomy in non-seminomatous stage I, IIa and IIb testicular tumors].
    Sparwasser C, Treiber U, Beckert R, Pust RA.
    Urologe A; 1995 Nov 20; 34(6):444-8. PubMed ID: 8848854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.